Barrett’s esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC), a highly lethal malignancy when detected late but treatable in its early stages. Surveillance programs are designed to identify neoplastic changes early, but the extremely low prevalence of neoplasia (<1%) poses major challenges for both clinical detection and the development of reliable computer-aided detection and diagnosis (CADe/x) systems. In such low-prevalence settings, developing traditional supervised machine learning models is challenging, often requiring artificially balanced datasets that do not reflect real-world deployment conditions, leading to limited generalization. In contrast, we propose reframing BE neoplasia detection as an out-of-distribution (OOD) problem, training generative models exclusively on healthy (non-dysplastic) images to identify rare pathological deviations. We systematically evaluate the trade-offs between supervised and generative approaches under varying prevalence and data regimes, and find that generative models offer a promising, prevalence-agnostic alternative in low-prevalence settings, although they still face limitations in sensitivity to subtle lesions. This study demonstrates the potential of generative OOD modeling as a prevalence-independent alternative for rare-event detection in BE surveillance settings, with broader implications for other low-prevalence domains in medical imaging and early cancer detection in general.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Robust Early Detection of Barrett’s Neoplasia: Addressing Low-Prevalence Challenges with Generative Modeling

  • Tim J. M. Jaspers,
  • Francisco Caetano,
  • Cris H. B. Claessens,
  • Carolus H. J. Kusters,
  • Haiko Middeljans,
  • Martijn R. Jong,
  • Rixta A. H. van Eijck van Heslinga,
  • Floor Slooter,
  • Albert Jeroen de Groof,
  • Jacques J. Bergman,
  • Peter H. N. De With,
  • Fons van der Sommen

摘要

Barrett’s esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC), a highly lethal malignancy when detected late but treatable in its early stages. Surveillance programs are designed to identify neoplastic changes early, but the extremely low prevalence of neoplasia (<1%) poses major challenges for both clinical detection and the development of reliable computer-aided detection and diagnosis (CADe/x) systems. In such low-prevalence settings, developing traditional supervised machine learning models is challenging, often requiring artificially balanced datasets that do not reflect real-world deployment conditions, leading to limited generalization. In contrast, we propose reframing BE neoplasia detection as an out-of-distribution (OOD) problem, training generative models exclusively on healthy (non-dysplastic) images to identify rare pathological deviations. We systematically evaluate the trade-offs between supervised and generative approaches under varying prevalence and data regimes, and find that generative models offer a promising, prevalence-agnostic alternative in low-prevalence settings, although they still face limitations in sensitivity to subtle lesions. This study demonstrates the potential of generative OOD modeling as a prevalence-independent alternative for rare-event detection in BE surveillance settings, with broader implications for other low-prevalence domains in medical imaging and early cancer detection in general.